Objective To investigate the medication and compatibility patterns of traditional Chinese medicine (TCM) compound patents in the treatment of epilepsy through data mining research.
Methods Data on TCM compound patents for treating epilepsy were retrieved from the China National Intellectual Property Administration's patent publication website. Descriptive analysis, association rule analysis, and cluster analysis were conducted using softwares such as Excel, Origin 2021, R 4.3.1 and Cytoscape 3.9.1, and the relevant topological property values were calculated to construct the core complex network.
Results A total of 346 TCM compound patents for treating epilepsy were included, involving 738 different herbs. The top 5 frequently used herbs were Acorus tatarinowii, Gastrodia elata, Buthus martensii, Eupolyphaga seu steleophaga, and Uncaria rhynchophylla. The predominant drug category was liver-soothing and wind-extinguishing drugs. Cluster analysis identified two major categories of drug combinations, and the core combination in the co-occurrence network was Rhizoma acori tatarinowii-Scorpio-Gastrodiae rhizoma-Bombyx batryticatus-Uncariae ramulus cum uncis. A total of 23 association rules were obtained.
Conclusion This study reveals the primary characteristics of treating epilepsy, which mainly focus on therapeutic directions such as soothing the liver and suppressing wind, calming wind to arrest convulsions, and calming the mind to tranquilize the spirit. It incorporates individualized dialectical diagnostic and treatment strategies, such as promoting blood circulation and resolving stasis, invigorating the spleen, and transforming phlegm. This discovery aims to provide reference and reference value for the clinical treatment of epilepsy in traditional Chinese medicine.
1.Pottkämper JCM, Hofmeijer J, van Waarde JA, et al. The postictal state-What do we know?[J]. Epilepsia, 2020, 61(6): 1045-1061. DOI: 10.1111/epi.16519.
2.赵晨阳, 陆璐, 周东. 《中国老年癫痫患者管理专家共识》解读[J]. 西部医学, 2023, 35(6): 781-786, 792. [Zhao CY, Lu L, Zhou D. Interpretation of consensus for the management of epilepsy in elderly patients[J]. Medical Journal of West China, 2023, 35(6): 781-786, 792.] DOI: 10.3969/j.issn.1672-3511.2023.06.001.
3.Thijs RD, Surges R, O'brient J, et al. Epilepsy in adults[J]. Lancet, 2019, 393(10172): 689-701. DOI: 10.1016/S0140-6736(18)32596-0.
4.刘颖, 于海波, 孔庆飞. 癫痫的治疗和药物发现现状[J]. 药学学报, 2021, 56(4): 924-938. [Liu Y, Yu HB, Kong QF. Current status of treatment and drug discovery for epilepsy[J]. Acta Pharmaceutica Sinica, 2021, 56(4): 924-938.] DOI: 10.16438/j.0513-4870.2020-1578.
5.中国药典2020年版. 一部[S]. 2020: 52-451.
6.国家中医药管理局《中华本草》编委会. 中华本草[M]. 上海: 上海科学技术出版社, 1999. 第9册: 738.
7.钟赣生, 主编. 中药学. 第10版[M]. 北京: 中国中医药出版社, 2016: 580-712.
8.Otasek D, Morris JH, Boucas J, et al. Cytoscape automation: empowering workflow-based network analysis[J]. Genome Biol, 2019, 20(1): 185. DOI: 10.1186/s13059-019-1758-4.
9.靳鸽, 冯志海, 李先行, 等. 国家专利的中药复方治疗原发性骨质疏松症用药规律研究[J]. 中国骨质疏松杂志, 2021, 27(9): 1343-1348. [Jin G, Feng ZH, Li XX, et al. Medication rules of Chinese herbal compound prescriptions for treating angina in national patent database based on multiple data miningt[J]. Chinese Journal of Osteoporosis, 2021, 27(9): 1343-1348.] DOI: 10.3969/j.issn.1006-7108.2021.09.019.
10.王紫轩, 但文超, 李彬, 等. 基于国家专利的中药复方治疗带状疱疹的用药规律分析[J].中国医药导报, 2023, 20(1): 127-131, 149. [Wang ZX, Dan WC, Li B, et al. Analysis of drug use rule of Chinese herbal compound prescription in the treatment of herpes zoster based on national patent[J]. China Medical Herald, 2023, 20(1): 127-131, 149.] DOI: 10.20047/j.issn1673-7210. 2023.01.29.
11.陈成笙, 景康, 郭艳蒙, 等.基于多元数据挖掘探析国家专利数据库中治疗心绞痛的中药复方组方规律 [J]. 中国中药杂志, 2023, 48(20): 5659-5667. [Chen CS, Jing K, Guo YM, et al. Medication rules of Chinese herbal compound prescriptions for treating angina in national patent database based on multiple data mining[J]. China Journal of Chinese Materia Medica, 2023, 48(20): 5659-5667.] DOI: 10.19540/j.cnki.cjcmm.20230626.501.
12.计亚东, 王净净, 石学慧, 等. 王净净教授中西医结合治疗小儿癫痫临床经验[J]. 湖南中医药大学学报, 2020, 40(4): 486-489. [Ji YD, Wang JJ, Shi XH, et al. Wang Jingjing's clinical experience in the treatment of pediatric epilepsy with integrated traditional Chinese and western medicine[J]. Journal of Hunan University of Chinese Medicine, 2020, 40(4): 486-489.] DOI: 10.3969/j.issn.1674-070X.2020.04.020.
13.吴婧, 董笑克, 李中浩, 等. 癫痫的发作机制及中医治疗思路[J]. 中医药导报, 2021, 27(6): 146-148. [Wu J, Dong XK, Li ZH, et al. Discussion on the mechanism of epileptic seizure and its treatment by Chinese medicine[J]. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 2021, 27(6): 146-148.] DOI: 10.13862/j.cnki.cn43-1446/r.2021.06.032.
14.刘晓燕, 崔亚东, 田合禄. 中医四气五味理论与脏腑补泻关系的探讨[J]. 世界中医药, 2021, 16(1): 121-124, 129. [Liu XY, Cui YD, Tian HL. Discussion on the relationship between the theory of four properties and five flavors in Chinese medicine and supplement and dispelling of Zang Fu[J]. World Chinese Medicine, 2021, 16(1): 121-124, 129.] DOI: 10.3969/j.issn.1673-7202.2021.01.018.
15.王小亮. 癫痫病因病机探讨[J]. 黑龙江中医药, 2013, 42(3): 8-10. [Wang XL. Discussion on the etiology and pathogenesis of epilepsy[J]. Heilongjiang Journal of Traditional Chinese Medicine, 2013, 42(3): 8-10.] DOI: 10.3969/j.issn.1000-9906.2013.03.004.
16.周德生, 蔡昱哲. 基于脑心与胆相通理论辨治癫痫病——中医脑病理论与临床实证研究(四)[J]. 湖南中医药大学学报, 2019, 39(4): 429-433. [Zhou DS, Cai YZ. Syndrome differentiation-based treatment of epilepsy based on the theory of brain heart and gallbladder connection: traditional Chinese medicine theory of encephalopathy and clinical empirical study (IV)[J]. Journal of Hunan University of Chinese Medicine, 2019, 39(4): 429-433.] DOI: 10.3969/j.issn.1674-070X.2019.04.001.
17.刘炳林. 痫证诊断与疗效评定标准[J]. 北京中医学院学报, 1993, 16(4): 13-14. [Liu BL. Diagnostic criteria for epilepsy[J]. Journal of Beijing University of Traditional Chinese Medicine, 1993, 16(4): 13-14.] http://old.cqvip.com/QK/93826X/199304/994002.html.
18.痫病的诊断依据、证候分类、疗效评定——中华人民共和国中医药行业标准《中医内科病证诊断疗效标准》(ZY/T001.1-94)[J]. 辽宁中医药大学学报, 2016, 18(8): 256. [Diagnosis basis, syndrome classification, and efficacy evaluation of epilepsy-industry standard of the people's republic of China《Diagnostic and Efficacy Standards for Internal Medicine Diseases of Traditional Chinese Medicine》(ZY/T001.1-94)[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2016, 18(8): 256.] https://www.cnki.com.cn/Article/CJFDTotal-LZXB201609071.htm.
19.苏发智, 孙延平, 白晨曦, 等. 中医药辨证治疗癫痫的研究进展[J]. 中国实验方剂学杂志, 2023, 29(11): 200-211. [Su FZ, Sun YP, Bai CX, et al. Epilepsy treated by traditional Chinese medicine based on syndrome differentiation: a review[J]. Chinese Journal of Experimental Traditional Medical Formulas, 2023, 29(11): 200-211.] DOI: 10.13422/j.cnki.syfjx.20220490.
20.刘春娟, 房彩连, 朱羽, 等. 石菖蒲复方的临床应用研究概况[J]. 食品与药品, 2023, 25(3): 256-261. [Liu CJ, Fang CL, Zhu Y, et al. Research Summary of clinical application of acorus tatarinowii schott compound[J]. Food and Drug, 2023, 25(3): 256-261.] DOI: 10.3969/j.issn.1672-979X.2023.03.014.
21.吴婧, 刘金涛, 刘冲冲, 等. 石菖蒲治疗癫痫的应用理论探析[J]. 中华中医药学刊, 2020, 38(12): 141-144. [Wu J, Liu JT, Liu CC, et al. Analysis of application theory of shichangpu (acorus tatarinowii schott) in treatment of epilepsy[J]. Chinese Archives of Traditional Chinese Medicine, 2020, 38(12): 141-144.] DOI: 10.13193/j.issn.1673-7717.2020.12.038.
22.袁文, 汤丹丹, 夏清. 基于网络药理学预测人参配伍石菖蒲治疗阿尔茨海默病的作用机制[J]. 中国药师, 2020, 23(12): 2306-2312. [Yuan W, Tang DD, Xia Q. Prediction of action mechanism of panax ginseng c.a.meyer combined with acorus tatarinowii schott in treating Alzheimer's disease based on network pharmacology[J]. China Pharmacist, 2020, 23(12): 2306-2312.] DOI: 10.3969/j.issn.1008-049X.2020.12.002.
23.赵颖, 徐薇薇, 王莹, 等. 石菖蒲抗癫痫药效物质及其机制研究进展[J]. 环球中医药, 2022, 15(10): 1977-1984. [Zhao Y, Xu WW, Wang Y, et al. Research progress on anti-epilepsy substance and their mechanisms in acorus tatarinowii schott[J]. Global Traditional Chinese Medicine, 2022, 15(10): 1977-1984.] DOI: 10.3969/j.issn.1674-1749.2022.10.046.
24.陈灼, 王豆, 李涛, 等. 石菖蒲抗癫痫的药理机制研究进展[J]. 中国实验方剂学杂, 2022, 28(18): 261-268. [Chen Z, Wang D, Li T, et al. Antiepileptic pharmacological mechanism of acori tatarinowii rhizoma: a review[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2022, 28(18): 261-268.] DOI: 10.13422/j.cnki.syfjx.20221008.
25.刘冲冲, 孙江燕, 袁斯远, 等. 柴贝止痫汤及α细辛醚对难治性癫痫大鼠脑内P-gP表达及卡马西平含量的影响[J]. 中华中医药杂志, 2020, 35(3): 1203-1206. [Liu CC, Sun JY, Yuan SY, et al. Effects of chaibei zhixian decoction and α-asarone on the P-gP expression and carbamazepine content in the brain of intractable epileptic rats[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2020, 35(3): 1203-1206. ] DOI: CNKI:SUN:BXYY.0.2020-03-040.
26.陈汉裕, 陈凤丽. 探析天麻钩藤药对的古今临床应用 [J]. 光明中医, 2014, 29(2): 391-392. [Chen HY, Chen FL. Analysis of the ancient and modern clinical application of tianma gouteng decoction[J]. Guangming Journal of Chinese Medicine, 2014, 29(2): 391-392.] DOI: 10.3969/j.issn.1003-8914.2014.02.103.
27.马建福, 王豆, 李涛, 等. 天麻及其有效成分对神经系统疾病的药理作用研究进展[J]. 中华中医药学刊, 2023, 41(1): 127-132. [Ma JF, Wang D, Li Tao, et al. Research progress on pharmacological effects of tianma (gastrodiae rhizoma) and its effective components on nervous system diseases[J]. Chinese Archives of Traditional Chinese Medicine, 2023, 41(1): 127-132.] DOI: 10.13193/j.issn.1673-7717.2023.01.029.
28.施盈盈, 顾卫卫. 血栓通联合天麻素注射液对后循环缺血性眩晕患者血管内皮功能和炎症因子的影响 [J].中国药师, 2024, 27(3): 447-454. [Shi YY, Gu WW. Effects of Xueshuantong combined with gastrodin injection on vascular endothelial function and inflammatory factors in patients with posterior circulation ischemic vertigo[J]. China Pharmacist, 2024, 27(3): 447-454.] DOI: 10.12173/j.issn.1008-049X.202311182.
29.李浩然, 吴宏赟, 彭伟. 天麻-钩藤药对治疗帕金森病的网络药理学研究[J]. 山东中医杂志, 2020, 39(12): 1344-1352. [Li HH, Wu HY, Peng W. Network pharmacology study on tianma (gastrodiae rhizoma)-gouteng (uncariae ramulus cum uncis) herbal pair in treating parkinson's disease[J]. Shandong Journal of Traditional Chinese Medicine, 2020, 39(12): 1344-1352.] DOI: 10.16295/j.cnki.0257-358x.2020.12.017.
30.马学淼, 杜晔, 程光宇, 等. 天麻钩藤饮加减配合针刺痫三针联合左乙拉西坦治疗癫痫的临床疗效观察[J]. 临床和实验医学杂志, 2023, 22(6): 602-605. [Ma XM, Du Y, Cheng GY, et al. Clinical observation on the clinical effect of Tianma Guoteng Yin and three acupuncture needles combined with levetiracetam in the treatment of epilepsy[J]. Journal of Clinical and Experimental Medicine, 2023, 22(6): 602-605.] DOI: 10.3969/j.issn.1671-4695.2023.06.011.
31.廖可欣, 宋渺渺, 肖爱娇, 等. 全蝎防治神经系统类疾病的研究进展[J]. 中药药理与临床, 2023, 39(1): 124-128. [Liao KX, Song MM, Xiao AJ, et al. Quanxie in preventing and treating nervous system diseases: a review[J]. Pharmacology and Clinics of Chinese Materia Medica, 2023, 39(1): 124-128.] DOI: 10.13412/j.cnki.zyyl.20220313.004.
32.胡美变, 何丽英, 王丹, 等. 基于GABA信号通路和神经-免疫-内分泌网络探讨米泔制僵蚕“粉末入药”的“息风止痉”作用机制[J]. 中药药理与临床, 2022, 38(5): 118-124. [Hu MB, He LY, Wang D, et al. Xifengzhijing mechanism of rice-washing water-processed Jiangcan powder based on GABA signaling pathway and neuro-immune-endocrine network[J]. Pharmacology and Clinics of Chinese Materia Medica, 2022, 38(5): 118-124.] DOI: 10.13412/j.cnki.zyyl.2022.05.003.
33.周丽丽, 薛征. 僵蚕、全蝎、蝉蜕治疗小儿抽动障碍的中西医机制探讨[J]. 中医文献杂志, 2023, 41(2): 105-108. [Zhou LL, Xue Z. Discussion on the mechanism of cockroach, whole scorpion, and cicada slough in the treatment of pediatric tic disorders from the perspective of traditional Chinese and western medicine[J]. Journal of Traditional Chinese Medical Literature, 2023, 41(2): 105-108.] DOI: 10.3969/j.issn.1006-4737.2023.02.030.
34.王丹, 李平, 陈云, 等. 定痫丸联合吡仑帕奈治疗成人局灶性癫痫临床研究[J]. 中西医结合研究, 2023, 15(1): 13-17. [Wang D, Li P, Chen Y, et al. Clinical study of dingxian pills combined with perampanel in the treatment of adult focal epilepsy[J]. Research of Integrated Traditional Chinese and Western Medicine, 2023, 15(1): 13-17.] DOI: 10.3969/j.issn.1674-4616.2023.01.003.
35.许霞, 余瀛鳌. 余瀛鳌教授治疗癫痫验案举隅[J]. 浙江中医药大学学报, 2016, 40(7): 543-544. [Xu X, Yu YA. The example of professor Yu Ying'ao's treatment of epilepsy[J]. Journal of Zhejiang Chinese Medical University, 2016, 40(7): 543-544.] DOI: 10.16466/j.issn1005-5509.2016.07.009.
36.陈睿洲, 朱子路, 王德恒. 定痫丸对海人藻酸诱导的小鼠癫痫行为干预作用研究[J]. 长春中医药大学学报, 2023, 39(4): 389-394. [Chen RZ, Zhu ZL, Wang DH. Study on the intervention effect of Dingxian pill on epileptic behavior induced by kainic acid in mice[J]. Journal of Changchun University of Chinese Medicine, 2023, 39(4): 389-394.] DOI: 10.13463/j.cnki.cczyy.2023.04.090.
37.张建明, 渠建宇. 六君子汤辅助丙戊酸钠治疗小儿癫痫临床观察[J]. 光明中医, 2019, 34(3): 411-412. [Zhang JM, Qu JY. Clinical observation on Liujunzi decoction and valproate in the treatment of pediatric epilepsy[J]. Guangming Journal of Chinese Medicine, 2019, 34(3): 411-412.] DOI: 10.3969/j.issn.1003-8914.2019.03.031.
38.陈冰, 张弈舒, 陈思邈, 等. 丹参与不同功效药物配伍后对成分及活性的影响[J]. 时珍国医国药, 2021, 32(3): 577-580. [Chen B, Zhang YS, Chen SM, et al. Effect of compatibility of Salvia miltiorrhiza with different effective herbs on components and activities[J]. Lishizhen Medicine and Materia Medica Research, 2021, 32(3): 577-580.] DOI: 10.3969/j.issn.1008-0805.2021.03.18.
39.吴素芹. 明清时期癫痫方分类及配伍规律[J]. 山东中医杂志, 2017, 36(6): 452-455, 458. [Wu SQ. The classification and compatibility of epilepsy formulas in the Ming and Qing dynasties[J]. Shandong Journal of Traditional Chinese Medicine, 2017, 36(6): 452-455, 458.] DOI: 10.16295/j.cnki.0257-358x.2017.06.004.
40.王咪咪, 编篡. 张锡纯医学论文集[M]. 北京: 学苑出版社, 2011: 15-20.
41.许金塔, 刘翔翔, 徐婕, 等. 基于中医传承计算平台探究牡蛎和煅牡蛎临床用药规律[J].中国海洋药物, 2023, 42(4): 63-70. [Xu JT, Liu XX, Xu J, et al. Clinical medication rules of oyster and calcined oyster based on traditional Chinese medicine inheritance computing system[J]. China Journal of Marine Drugs, 2023, 42(4): 63-70.] DOI: 10.13400/j.cnki.cjmd.2023.04.003.
42.王楚杰, 于征淼. 癫痫患者中医证素与长程脑电特点的关系研究[J]. 广州中医药大学学报, 2022, 39(1): 12-18. [Wang CJ, Yu ZM. Relationship of traditional Chinese medicine syndrome elements with long-term electroencephalogram of epilepsy patients[J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2022, 39(1): 12-18.] DOI: 10.13359/j.cnki.gzxbtcm.2022. 01.003.
43.宋哲, 黄志艳, 冯钰, 等. 基于数据挖掘研究含石菖蒲-远志药对方剂的组方规律[J]. 中国中药杂志, 2022, 47(6): 1687-1693. [Song Z, Huang ZY, Feng Y, et al. Data mining-based analysis of formulation rules for prescriptions containing herbal pair Acori Tatarinowii Rhizoma-Polygalae Radix[J]. China Journal of Chinese Materia Medica, 2022, 47(6): 1687-1693.] DOI: 10.19540/j.cnki.cjcmm.20211203.502.
44.邸学, 王一博, 刘雅晴, 等. 远志-石菖蒲药对不同配比对PC12细胞凋亡的影响[J]. 生物化工, 2022, 8(4): 70-73. [Di X, Wang YB, Liu YQ, et al. The effects of protection PC12 cells by different components of acorus tatarinowii and polygala tenuifolia[J]. Biological Chemical Engineering, 2022, 8(4): 70-73.] DOI: 10.3969/j.issn.2096-0387.2022.04.016.
45.蔡鑫, 郭军军, 李昌繁, 等. 浅析虫类药在治疗多发性抽动症中的应用[J]. 内蒙古中医药, 2023, 42(2): 119-121. [Cai X, Guo JJ, Li CF, et al. Analysis of the application of insect drugs in the treatment of tourette syndrome[J]. Inner Mongolia Journal of Traditional Chinese Medicine, 2023, 42(2): 119-121.] DOI: 10.16040/j.cnki.cn15-1101.2023.02.026.
46.靳梦亚, 李志远. 基于数据挖掘的心血管科中药处方用药规律分析及药物警戒[J]. 药物流行病学杂志, 2023, 32(3): 241-248. [Jin MY, Li ZY. Analysis and pharmacovigilance of traditional Chinese medicine prescriptions in cardiovascular department based on data mining[J]. Chinese Journal of Pharmacoepidemiology, 2023, 32(3): 241-248.] DOI: 10.19960/j.issn.1005-0698. 202303001.
47.夏鑫, 牟玮, 李艳芬, 等. 基于机器学习技术挖掘中医名家医案数据的方法探讨[J]. 医学新知, 2024, 34(4): 448-457. [Xia X, Mu W, Li YF, et al. Approaches to the mining of traditional Chinese medical experts' case histories using machine learning techniques[J]. Yixue Xinzhi Zazhi, 2024, 34(4): 448-457.] DOI: 10.12173/j.issn.1004-5511.202312129.